FDA Gastroenterology, Radiology Advisors Finally Agree: CT Colonography Benefits Outweigh Risks
New research findings presented at a joint meeting of FDA’s gastroenterology and radiological devices panels persuaded experts that CT colonography is safe and works well for screening adults over 50 for colorectal cancer.
You may also be interested in...
Two FDA advisory panels will come together Sept. 9 to consider the latest evidence supporting computed tomography colonography as a general screening tool for colorectal cancer. The technique has been touted as a less invasive option to traditional colonoscopy, but its use has been strongly questioned due to risks from radiation exposure and false positives.
Advances in imaging and interventional endoscopy are improving cancer detection and enabling less invasive approaches to diagnose and treat disorders in the gastrointestinal tract. These emerging procedures are poised to fuel growth in the $7 billion global market for GI endoscopy.
Competitive value propositions are a must in 2023 to win guarded consumers’ business. Companies that effectively address mental health and wellbeing needs and appeal to consumers through sustainability initiatives could have an edge in the recessionary environment, experts suggest. Meanwhile, there are concerns about small cosmetics companies and the availability of resources to help them comply with "modernized" federal regulations.